NCT02489006View on ClinicalTrials.gov

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 19, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Ovarian CancerFallopian Tube CancerNeoadjuvant TreatmentDebulking Surgical Procedures
Interventions
DRUG

Olaparib

DRUG

Platinum-based Chemotherapy

Chosen by the study doctor, per standard of care.

Trial Locations (9)

T2N 4N2

Tom Baker Cancer Centre, Calgary

K1H 8L6

Ottawa Regional Cancer Centre, Ottawa

M5G 2M9

Princess Margaret Cancer Centre, Toronto

H2L 2W5

Centre hospitalier de l'Université de Montréal (CHUM, Montreal

H3T 1E2

Jewish General Hospital, Montreal

Unknown

Auckland City Hospital, Grafton

Imperial College Healthcare NHS Trust, London

08035

Vall d'Hebron University Hospital, Barcelona

SW3 6JJ

Royal Marsden Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

University Health Network, Toronto

OTHER